Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...
Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...